Provided by Tiger Trade Technology Pte. Ltd.

Statera Biopharma Inc

0.0002
0.0000
Volume:648.00
Turnover:0.13
Market Cap:14.52K
PE:0.00
High:0.0002
Open:0.0002
Low:0.0002
Close:0.0002
52wk High:0.0133
52wk Low:0.0000
Shares:72.58M
Float Shares:63.88M
Volume Ratio:0.70
T/O Rate:0.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8100
EPS(LYR):-2.9009
ROE:-286.94%
ROA:-23.85%
PB:-0.00
PE(LYR):0.00

Loading ...

Company Profile

Company Name:
Statera Biopharma Inc
Exchange:
EXPERT
Establishment Date:
- -
Employees:
46
Office Location:
4333 Corbett Drive,,Suite 1082,Fort Collins,Colorado,United States
Zip Code:
80525
Fax:
- -
Introduction:
Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within patients a response of antigen-specific killer T-cells and antibodies, thereby activating essential immune defenses against autoimmune, inflammatory, infectious diseases, and cancers. It has clinical programs for Crohn's disease (STAT-201), hematology (Entolimod), pancreatic cancer (STAT-401), and COVID-19 (STAT-205), as well as fibromyalgia and multiple sclerosis. The company was formerly known as Cytocom, Inc. and changed its name to Statera Biopharma, Inc. in September 2021. Statera Biopharma, Inc. is based in Fort Collins, Colorado. Statera Biopharma, Inc. operates as a subsidiary of Biostax Corp.